Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-25 @ 11:38 PM
NCT ID:
NCT02322593
Group ID:
EG001
Title:
S-1/Cisplatin
Description:
S-1 plus Cisplatin
CDDP was administered intravenously at dose of 60 mg/m2 on day 1 (Korea) or day 8 (Japan), and S-1 were administered 40-60 mg orally twice daily for 21 days (day 1 through day 21), repeated every 5 weeks (rest period can be shorten from 14 days to 7 days). Treatment was continued during the study period unless any of Study Treatment Discontinuation Criteria was met.
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
159
Serious Number At Risk:
348
Other Number Affected:
328
Other Number At Risk:
348
Study:
NCT02322593
Results Section:
NCT02322593
Adverse Events Module:
NCT02322593